Evaluation of Urinary Tissue Inhibitor of Metalloproteinase‐2 (TIMP‐2), Insulin‐Like Growth Factor–Binding Protein‐7 (IGFBP‐7), and Kidney Injury Molecule‐1 (KIM‐1) as Biomarkers for the Detection of Meloxicam‐Induced Kidney Injury in Cats
- 18 January 2026
- journal article
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 36 (1) , 39-44
Abstract
Objective: To evaluate the concentration versus time course profiles of urinary tissue inhibitor of metalloproteinase‐2 (TIMP‐2), insulin‐like growth factor–binding protein‐7 (IGFBP‐7), and kidney injury molecule‐1 (KIM‐1) during repeated administrations of meloxicam, and determine whether these profiles differ from saline‐treated cats. Design: Placebo‐controlled experimental design performed in 2017. Animals: Twelve healthy, adult, purpose‐bred female cats. Interventions: Cats were randomly allocated to control and treatment groups. Cats in the treatment group ( n = 6) received meloxicam 0.3 mg/kg subcutaneously every 24 h for 31 days. Cats in the control group ( n = 6) received saline (0.1 mL/kg subcutaneously). Measurements and Main Results: Urinary TIMP‐2, IGFBP‐7, KIM‐1, and creatinine were measured every 4–6 days for 31 days, along with serum creatinine. In the treatment group, cats were determined to have renal injury if at least one kidney had histopathological evidence of tubular damage, basement membrane damage, and/or interstitial inflammation. The urinary biomarker concentrations between control and renal injury groups were compared by calculating the area under the curve (AUC) for each biomarker normalized for urine creatinine (UC) concentration versus time course profile and reported as mean ± SE. The AUC values for the two groups were compared statistically using an unpaired, two‐tailed t ‐test. The AUC for urinary IGFBP‐7/UC was higher ( p = 0.0152) in the treatment group (0.042 ± 0.0062) compared to the control group (0.02676 ± 0.0018). The AUC for urinary KIM‐1/UC was higher ( p = 0.0083) in the treatment group (0.034 ± 0.0055) compared to the control group (0.019 ± 0.0022). An increase in urinary TIMP‐2 was detected in only 50% of the treatment group. Conclusions: Urinary IGFBP‐7 and KIM‐1 increase in cats that develop acute kidney injury after repeated meloxicam administration. Further studies are needed before the clinical utility of these molecules as biomarkers for early acute kidney injury detection in cats can be determined.Keywords
This publication has 27 references indexed in Scilit:
- International Renal Interest Society best practice consensus guidelines for the diagnosis and management of acute kidney injury in cats and dogsThe Veterinary Journal, 2024
- Urinary Biomarkers of Kidney Disease in Dogs and CatsVeterinary Clinics of North America: Small Animal Practice, 2022
- Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus ConferenceJAMA Network Open, 2020
- Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspectiveBiochemical Pharmacology, 2020
- Evaluating the Use of KIM‐1 in Drug Development and Research Following FDA QualificationClinical Pharmacology & Therapeutics, 2018
- Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Cutaneous T-Cell Lymphoma Cells and Enhance Their Sensitivity for TNF-Related Apoptosis-Inducing LigandJournal of Investigative Dermatology, 2012
- Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2011
- Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rateKidney International, 2010
- Tubular kidney injury molecule‐1 (KIM‐1) in human renal diseaseThe Journal of Pathology, 2007
- Estimation of Confidence Intervals for Area Under the Curve from Destructively Obtained Pharmacokinetic DataJournal of Pharmacokinetics and Biopharmaceutics, 1998